Irbesartan in hypertensive patients with left ventricular hypertrophy.

Trial Profile

Irbesartan in hypertensive patients with left ventricular hypertrophy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 May 2011

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms I-SELECT
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Dec 2008 Planned number of patients changed from 418 to 268 as reported by ClinicalTrials.gov.
    • 10 Apr 2008 The expected completion date for this trial is now 1 Jan 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top